JP2007505883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505883A5 JP2007505883A5 JP2006526715A JP2006526715A JP2007505883A5 JP 2007505883 A5 JP2007505883 A5 JP 2007505883A5 JP 2006526715 A JP2006526715 A JP 2006526715A JP 2006526715 A JP2006526715 A JP 2006526715A JP 2007505883 A5 JP2007505883 A5 JP 2007505883A5
- Authority
- JP
- Japan
- Prior art keywords
- parathyroid hormone
- composition
- osteoporosis
- treating
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000003982 Parathyroid hormone Human genes 0.000 claims 5
- 108090000445 Parathyroid hormone Proteins 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 239000000199 parathyroid hormone Substances 0.000 claims 5
- 229960001319 parathyroid hormone Drugs 0.000 claims 5
- 208000001685 Postmenopausal Osteoporosis Diseases 0.000 claims 2
- 206010003549 Asthenia Diseases 0.000 claims 1
- 210000000988 Bone and Bones Anatomy 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 206010017076 Fracture Diseases 0.000 claims 1
- 206010028315 Muscle injury Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010049088 Osteopenia Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 206010039984 Senile osteoporosis Diseases 0.000 claims 1
- 239000011612 calcitriol Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (6)
- 化合物：２−メチレン−１９−ノル−２０（Ｓ）−１α，２５−ジヒドロキシビタミンＤ３と副甲状腺ホルモン又はその活性断片又は変異体を含む医薬組成物。
- 副甲状腺ホルモンがヒト組換え副甲状腺ホルモンである、請求項１の組成物。
- 副甲状腺ホルモンがヒト組換え副甲状腺ホルモン１−３４である、請求項１の組成物。
- 老年性骨粗鬆症、閉経後骨粗鬆症、骨折、移植骨片、乳癌、前立腺癌、肥満、骨減少症、男性骨粗鬆症、虚弱、筋損傷、又は肉減少症を治療するための、請求項１〜３のいずれか１項に記載の組成物。
- 閉経後骨粗鬆症を治療するための、請求項１〜３のいずれか１項に記載の組成物。
- 骨折を治療するための、請求項１〜３のいずれか１項に記載の組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50450303P | 2003-09-19 | 2003-09-19 | |
| PCT/IB2004/002902 WO2005027915A1 (en) | 2003-09-19 | 2004-09-06 | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505883A JP2007505883A (ja) | 2007-03-15 |
| JP2007505883A5 true JP2007505883A5 (ja) | 2007-11-08 |
Family
ID=34375509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526715A Pending JP2007505883A (ja) | 2003-09-19 | 2004-09-06 | ２−アルキリデン−１９−ノル−ビタミンｄ誘導体及び副甲状腺ホルモンの組合せを含んでなる医薬組成物及び方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20050065088A1 (ja) |
| EP (1) | EP1667689A1 (ja) |
| JP (1) | JP2007505883A (ja) |
| KR (1) | KR20060058133A (ja) |
| CN (1) | CN1852716A (ja) |
| AU (1) | AU2004273660B2 (ja) |
| BR (1) | BRPI0414518A (ja) |
| CA (1) | CA2539357A1 (ja) |
| IL (1) | IL174144A0 (ja) |
| MX (1) | MXPA06003064A (ja) |
| NO (1) | NO20061236L (ja) |
| NZ (1) | NZ545803A (ja) |
| RU (1) | RU2006108557A (ja) |
| TW (1) | TW200511999A (ja) |
| WO (1) | WO2005027915A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122533B2 (en) * | 1999-11-29 | 2006-10-17 | The United States Of America As Represented By The Department Of Health And Human Services | Cosalane compounds and methods for their use |
| JP2007512371A (ja) * | 2003-11-25 | 2007-05-17 | デルタノイド ファーマシューティカルズ，インコーポレイティド | ビタミン化合物を用いる体脂肪の減少方法 |
| WO2005051323A2 (en) | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
| AU2006213722B2 (en) * | 2005-02-11 | 2011-09-22 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin-D2 |
| EP1853274B1 (en) * | 2005-02-11 | 2013-01-23 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor- (20s-24s) - 1alpha, 25-dihydroxyvitamine-d2 |
| US7235680B2 (en) * | 2005-03-29 | 2007-06-26 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone |
| EP2556054B1 (en) * | 2010-03-23 | 2017-09-27 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| AU2011232633B2 (en) | 2010-03-23 | 2014-05-29 | Wisconsin Alumni Research Foundation | (20S)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22- dimethyl-1alpha,25-hydroxyvitamin D3 |
| US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
| WO2015050160A1 (ja) * | 2013-10-03 | 2015-04-09 | 国立大学法人大阪大学 | 副甲状腺ホルモンまたはその誘導体を有効成分とする筋の老化防止用医薬組成物 |
| JP6566520B2 (ja) * | 2013-10-29 | 2019-08-28 | 国立大学法人 熊本大学 | 筋疾患の治療または予防のための医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
| US5086191A (en) * | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
| EP0619306B1 (en) * | 1993-04-05 | 1996-09-11 | Wisconsin Alumni Research Foundation | 19-Nor-vitamin D3 compounds with substituent at 2-position |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
| DZ2873A1 (fr) * | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Procédé pour augmenter la dureté et la rigidité osseuse. |
| EP1136076A1 (en) * | 1998-08-19 | 2001-09-26 | Eli Lilly And Company | Method of increasing bone toughness and stiffness and reducing fractures |
-
2004
- 2004-09-06 JP JP2006526715A patent/JP2007505883A/ja active Pending
- 2004-09-06 AU AU2004273660A patent/AU2004273660B2/en not_active Expired - Fee Related
- 2004-09-06 RU RU2006108557/15A patent/RU2006108557A/ru not_active Application Discontinuation
- 2004-09-06 BR BRPI0414518-6A patent/BRPI0414518A/pt not_active IP Right Cessation
- 2004-09-06 EP EP04769301A patent/EP1667689A1/en not_active Withdrawn
- 2004-09-06 WO PCT/IB2004/002902 patent/WO2005027915A1/en active Application Filing
- 2004-09-06 KR KR1020067005457A patent/KR20060058133A/ko not_active Application Discontinuation
- 2004-09-06 MX MXPA06003064A patent/MXPA06003064A/es unknown
- 2004-09-06 CA CA002539357A patent/CA2539357A1/en not_active Abandoned
- 2004-09-06 CN CNA2004800268486A patent/CN1852716A/zh active Pending
- 2004-09-06 NZ NZ545803A patent/NZ545803A/en unknown
- 2004-09-16 US US10/946,585 patent/US20050065088A1/en not_active Abandoned
- 2004-09-17 TW TW093128228A patent/TW200511999A/zh unknown
-
2006
- 2006-03-06 IL IL174144A patent/IL174144A0/en unknown
- 2006-03-17 NO NO20061236A patent/NO20061236L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007505883A5 (ja) | ||
| WO2007028633A3 (en) | Treatment of diabetes related obesity | |
| JP2006143751A5 (ja) | ||
| WO2005115441A3 (en) | Compositions and methods for enhanced mucosal delivery of parathyroid hormone | |
| DE602004013971D1 (de) | Marknagel zur Behandlung von proximalen Oberschenkelknochenbrüchen | |
| LTC1562603I2 (lt) | Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui | |
| JP2008512426A5 (ja) | ||
| JP2005529969A5 (ja) | ||
| HK1077998A1 (en) | Apparatuses for therapeutically treating damaged tissues, bone fractures, osteopenia, or osteoporosis | |
| IL184554A0 (en) | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases | |
| IL158593A (en) | Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders | |
| CA2512229A1 (en) | Clavicular bone plate | |
| MXPA04003858A (es) | Antagonistas de mch para el tratamiento de obesidad. | |
| WO2005072277A3 (en) | Amidated parathyroid hormone fragments and uses thereof | |
| JP2011519960A5 (ja) | ||
| NZ594814A (en) | Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent | |
| WO2009010968A3 (en) | Disease treatment via antimicrobial peptides or their inhibitors | |
| EA201070725A1 (ru) | Бис-пиридилпиридоны как антагонисты рецептора 1 меланинконцентрирующего гормона | |
| DE602004029465D1 (de) | Externes Präparat zur Behandlung von Fusspilz | |
| NO20040598L (no) | 5-CNAC som oralt avleveringsmiddel for paratyreoidhormonfragmenter. | |
| JP2007505881A5 (ja) | ||
| JP2005509503A5 (ja) | ||
| RU2006108557A (ru) | Фармацевтические композиции, включающие в себя сочетания производных 2-алкилиден-19-нор-витамина d и паратиреоидного гормона, и способы (лечения) | |
| TW200628168A (en) | Use of organic compounds | |
| Choi et al. | Management of mandibular angle fractures using the mandibular angle reduction forceps |